Pathological Myopia

• CLINICAL_TRIALS research · 2025-12-18
  Clinical Trial Update: Retinal Clinical Assessment With AI-derived Quantitative Information

  This clinical trial update describes an AI-derived retinal imaging assessment intended to provide quantitative information across several re…

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

  A protocol for an interpretable fundus disease report generator using weakly labeled data, sponsored by Zhongshan Ophthalmic Center, Sun Yat…

• CLINICAL_TRIALS trial_result · 2019-03-11
  Clinical Trial Update: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization [Phase 4]

  Phase 4 trial update on dosing strategy for intravitreal ranibizumab in choroidal neovascularization associated with pathological myopia.

• CLINICAL_TRIALS research · 2017-04-25
  Clinical Trial Update: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

  This clinical trial update describes a pharmacogenomic study of the anti-VEGF drug Conbercept for macular neovascular diseases, including ag…

• CLINICAL_TRIALS trial_result · 2013-10-18
  Clinical Trial Update: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]

  Phase 3 trial assessing ranibizumab for visual impairment due to choroidal neovascularization from pathologic myopia; completed with results…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2010-06-09
  Clinical Trial Update: Genomewide Screening of Pathological Myopia

  Clinical trial update on genome-wide screening related to pathological myopia, sponsored by National Taiwan University Hospital.

• CLINICAL_TRIALS trial_result · 2009-02-03
  Clinical Trial Update: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) [Phase 1]

  Phase 1 trial evaluating bevacizumab (Avastin) infusion for choroidal neovascularization not associated with age-related macular degeneratio…